Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRACE-TB：NGS-guided Regimens of Anti-tuberculosis Drugs for the Control and Eradication of MDR-TB

NCT03604848 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT03604848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03604848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRACE-TB：NGS-guided Regimens of Anti-tuberculosis Drugs for the Control and Eradication of MDR-TB
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 5, 2018
Completion date
August 4, 2024
Enrollment
488 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug resistant tuberculosis